Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen

AIM: To explore the effect of TEC chemotherapy regimen (Docetaxel + Epirubicin + Cyclophosphamide) on traditional cardiovascular risk factors, atherosclerotic cardiovascular disease and cardiac electrical activity. DESIGN: 243 patients with first initially diagnosed breast cancer were collected who...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zhaoying, Liu, Zhaojun, Chen, Siyu, Zhang, Changhong, Xiao, Jun, Zhou, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685860/
https://www.ncbi.nlm.nih.gov/pubmed/34592784
http://dx.doi.org/10.1002/nop2.1059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685860/
https://www.ncbi.nlm.nih.gov/pubmed/34592784
http://dx.doi.org/10.1002/nop2.1059

Ejemplares similares